A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.
|Articles|August 1, 2004
- Volume 0 0
Updated Information on Melatonin Is Available
Advertisement
The National Sleep Foundation (NSF) has developed abrochure, "Melatonin: The Basic Facts," to address the growinguse of melatonin to help improve sleep. The brochure answersthe following questions:
- How does the sleep?wake cycle work?
- What is melatonin?
- Why is melatonin available without a prescription?
- Why do individuals take melatonin?
- What has been learned about melatonin from research studies?
For more information about the brochure, visit the NSF Website at www.sleepfoundation.org.
Articles in this issue
about 22 years ago
Training Reinforcementsabout 22 years ago
Hospice Care: Pharmacotherapy for Comfort Careabout 22 years ago
Finger Pointing by Doctor and Pharmacist Over Refillsabout 22 years ago
Pharmacist's Counseling Guide for Obesity Managementabout 22 years ago
A Gaining Trend: Obesity in the United Statesabout 22 years ago
Fructose May Lead to Overeatingabout 22 years ago
Obesity Rates Climb in the Elderlyabout 22 years ago
Food Regulations Are Proposed Abroadabout 22 years ago
Weight Loss in Obese Women Improves Lung Functionabout 22 years ago
Obesity Hinders Sexual FunctioningAdvertisement
Related to this article
Understanding local health care priorities is essential to developing meaningful solutions.
Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.
The most enduring resources a preceptor can give students are the confidence and tools to ask deeper questions.
Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.
Two recent graduates share strategies for standing out in the competitive fellowship application process.
Community pharmacies are access points, safe places, and sources of stability when everything else feels uncertain.
Impostor syndrome prevalence in oncology pharmacists is a complex topic that is not well described.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
2
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
3
CagriSema Tied to 25% Weight Loss in Women, Post Hoc Data Show
4
Kidney Week 2026: What to Know for Nephrology's Biggest Meeting
5